AstraZeneca bottom of the FTSE after Q4 earnings miss
Q4 earnings miss consensus expectations2024 guidance in line with forecastsEPS expected to increase 12% to 14%A fourth quarter earnings miss and in line 2024 guidance was enough to send AstraZeneca (AZN) to the bottom of the FTSE...
08 February 2024